Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Tailin Bioengineering is a China-based public company that develops, manufactures, and sells life science and pharmaceutical production equipment, microbial detection systems, sterility testing products, isolators, VHPS biodecontamination systems, and TOC analytical instruments. The company serves pharmaceutical manufacturing, medical research, cell and gene therapy, biosafety laboratories, food safety, disease control, and environmental protection markets. Tailin appears to be primarily a tools-and-equipment company rather than a therapeutic drug developer, with its core business centered on sterile assurance, contamination control, and laboratory/production workflow solutions. It has multiple wholly owned subsidiaries focused on life science, medical engineering, analytical instruments, and related businesses, and it manufactures much of its critical equipment in-house. The company is listed on the Shenzhen Stock Exchange and markets itself as an integrated solution provider in life science.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Tailin Bioengineering.